Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
renal disease
Biotech
AstraZeneca pays CSPC $30M to form kidney drug discovery pact
AstraZeneca has committed up to $1.7 billion in milestones to jointly discover and develop two kidney disease drug candidates with CSPC.
Nick Paul Taylor
Jul 3, 2026 8:00am
Quest Diagnostics to claim Fresenius’ dialysis testing portfolio
Feb 26, 2025 11:00am
eGenesis announces 2nd pig kidney transplant success
Feb 7, 2025 2:10pm
Pfizer and Flagship add Quotient to multibillion-dollar equation
Aug 28, 2024 6:30am
Revivicor sees 61 days' function in kidney+thymus xenotransplant
Sep 25, 2023 9:45am
Racing Bayer, Merck gets FDA fast-track tag for anticoagulant
Aug 23, 2022 8:40am
